Overview


According to FutureWise analysis, the market for Airlift Bioreactors is estimated to be US$ 2.4 billion in 2023 and is expected to reach US$ 5.7 billion by 2031 at a CAGR of 11.4% over the forecast period of 2023-2031.

Airlift bioreactors function as tower reactors suitable for large-scale aerobic cultures. The mixing of the culture broth is achieved through an airlift pump mechanism. In the setup, compressed air is introduced at the base of the discharge pipe, which is submerged in the liquid. Airlift bioreactors find versatile utility in producing biopharmaceuticals like therapeutic proteins, antibodies, vaccines, and enzymes. Their distinct design and operational features render them well-suited for diverse applications spanning bio-pharmaceutical manufacturing, bio-processing, regenerative medicine, waste treatment, and biochemical production. These bioreactors serve as cultivation platforms for microalgae and plant cells, yielding biofuels, nutraceuticals, pigments, and other high-value compounds. Notably, airlift bioreactors play a pivotal role in tissue engineering and regenerative medicine, offering a controlled milieu for cell and tissue culture, supporting proliferation, differentiation, and extracellular matrix synthesis.

The significance of airlift bioreactors is underscored by their crucial contributions to the production landscape, furnishing efficient and scalable bioprocessing capabilities. The core essence of a bioprocess continues to reside within the bioreactor, as it profoundly influences the efficacy of effective separation and, by extension, the overall product cost. Bioreactor are renowned for its processing attributes – including efficient mixing, minimal shear forces, simplicity in operation with immobilized microorganisms, and energy frugality – the airlift bioreactors. Exploration commences with fundamental engineering aspects of bioreactors, encompassing mass balances, mass transfer, and modeling, progressing towards an exploration of hydrodynamics and rheology within the process. The market experienced a notable surge in adopting airlift bioreactors to address escalated production demands amid the pandemic. Nevertheless, non-COVID-19-related projects, including those involving airlift bioreactors, faced temporary setbacks as resources were redirected toward pandemic response endeavours. 

FutureWise Market Research has published a report that provides an insightful analysis of Airlift Bioreactors Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Airlift Bioreactors Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Sartorius A.G.
  • Lonza
  • Shree Biocare
  • Knik Technology
  • Electrolab Biotech
  • Rotech Inc.
  • Cellexus
  • Solida Biotech GmBH.
  • Zeta GmbH.
  • Kuhner Shaker

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Development in Airlift Bioreactors Market:

  • In March 2022, Cellexus, a life sciences firm situated in Dundee, collaboratively partnered with Verder Liquids, a Castleford-based company, to provide pumps designed for the acid/base pump component that is an inherent part of their CellMaker Plus and Low Flow bioreactor systems. These systems are extensively utilized by researchers globally to cultivate cells within laboratory settings, serving as a foundational tool for experiments aimed at developing novel drugs and vaccines.

The airlift bioreactor market is witnessing substantial growth driven by several key factors. Biotechnology is rapidly advancing, embracing genetic engineering and innovative cell culture methodologies. This momentum has spurred a heightened demand for state-of-the-art bioreactor systems featuring airlift bioreactors. These systems stand out for their heightened efficiency and scalability, rendering them a favored choice, especially within the dynamic biopharmaceutical sector. The escalating need for therapeutic proteins, antibodies, vaccines, and other biopharmaceutical entities further amplifies the adoption of airlift bioreactors. Concurrently, the global emphasis on sustainability and eco-friendly practices resonates harmoniously with the environmentally conscious attributes of airlift bioreactors. Their intrinsic ability to cultivate microorganisms for biofuels, enzymes, and other high-value compounds caters precisely to the escalating demand for bio-based products. Furthermore, the role of airlift bioreactors in regenerative medicine and tissue engineering is pivotal. By offering controlled environments conducive to cell culture, proliferation, and differentiation, these bioreactors contribute significantly to advancing novel therapeutic modalities.

However, challenges persist. Technical intricacies surrounding design, setup, and operation necessitate specialized expertise. The scalability of airlift bioreactor systems to accommodate large-scale production also requires meticulous attention to consistent performance and optimal mass transfer. In addition, rivalry from alternative bioreactor technologies, such as stirred tank reactors and membrane bioreactors, shapes the competitive landscape.

By Product

  • Internal airlift loop bioreactor
  • External airlift loop bioreactor

By Material

  • Stainless steel
  • Glass

By Capacity

  • 5L
  • 7L
  • 10L
  • 30L

By Usage

  • Single-use / disposal
  • Reusable

By Production Scale

  • Laboratory scale
  • Pilot-scale
  • Large scale

By End-Users

  • Biopharmaceutical companies
  • Contract research organizations (CROs)/ Contract development and manufacturing organizations (CDMOs)
  • Research and development companies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. In 2022, North America emerged as the dominant player in the airlift bioreactors market, driven by advancements in biotechnology, frequent product launches, and other supportive factors. The region boasts a robust infrastructure for bio-pharmaceutical manufacturing, with the United States alone accounting for about one-third of the global bio-pharmaceutical market and leading in bio-pharmaceutical R&D. This rich ecosystem attracts significant investments in biotechnology and biopharmaceutical sectors, consequently fuelling the adoption of airlift bioreactors. Meanwhile, the Asia Pacific region is positioned as the fastest-growing market, poised for substantial expansion. The surge in demand for bio-based products propels its growth, particularly notable in China's focus on ethanol production. Airlift bioreactors offer distinct advantages, including improved mass transfer and enhanced oxygen transfer rates, making them an attractive choice for bio-based manufacturing. This pivotal feature is expected to drive revenue growth in the Asia Pacific market, cementing its position as a significant contributor to the industry's progress. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the of Airlift Bioreactors Market By Product, By Material, By Usage, By Capacity, By Production Scale, By End-Users and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represents in format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Airlift Bioreactors Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Airlift Bioreactors Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Airlift Bioreactors Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Airlift Bioreactors Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Internal airlift loop bioreactor
        2. External airlift loop bioreactor

  • 8.   Airlift Bioreactors Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Stainless steel
        2. Glass

  • 9.   Airlift Bioreactors Market, By Capacity Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. 5L
        2. 7L
        3. 10L
        4. 30L

  • 10.   Airlift Bioreactors Market, By Usage Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Single-use / disposal
        2. Reusable

  • 11.   Airlift Bioreactors Market, By Production Scale Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Laboratory scale
        2. Pilot-scale
        3. Large scale

  • 12.   Airlift Bioreactors Market, By End-Users Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Dental Clinics
        3. Others

  • 13.   North America Airlift Bioreactors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 14.   Latin America Airlift Bioreactors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 15.   Europe Airlift Bioreactors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 16.   Asia Pacific Airlift Bioreactors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 17.   Middle East and Africa Airlift Bioreactors Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 18.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 19.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Sartorius A.G.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Lonza
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Shree Biocare
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Knik Technology
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Electrolab Biotech
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Rotech Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Cellexus
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Solida Biotech GmBH.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Zeta GmbH.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Kuhner Shaker
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 20.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 21.   FutureWise SME Key Takeaway Points for Client

Related Market

Bioreactors Market

Read More

Single Use Bioreactors Market

Read More

Bioreactors and Fermenters Market

Read More
Partner

Our Clients